COMMUNIQUÉS West-GlobeNewswire

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering
13/08/2025
BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat [...]

Pages